Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Penumbra Inc's Business Segments
Penumbra Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
2
Largest Segment
Thrombectomy
Total Revenue
$ 390
Regions Reported
1
Revenue Share by Reportable Segment - FY
- Thrombectomy65.1%
- Embolization and Access31%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Thrombectomy | $ 254 | 65.1% |
| Embolization and Access | $ 121 | 31% |
Revenue Share by Region - FY
- Non-US20.9%
Revenue by Geographic Region - FY
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Non-US | $ 78 | 20.9% |
Revenue by Product & Service Category - FY
- Thrombectomy67.8%
- Embolization and Access32.2%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Thrombectomy | $ 254 | 67.8% |
| Embolization and Access | $ 121 | 32.2% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Annual Results
Revenue Share by Reportable Segment - FY
- Thrombectomy65.1%
- Embolization and Access31%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Thrombectomy | $ 254 | 65.1% |
| Embolization and Access | $ 121 | 31% |
Description of Penumbra Inc
Penumbra Inc. is a California-based medical device company that's focused on the development and manufacturing of innovative medical technologies for the treatment of neurological and vascular disorders. The company's portfolio of products includes neurovascular access, neurovascular intervention, neurointensive care, and related products for stroke and neurovascular disorders, including cerebral aneurysms, intracranial atherosclerosis, and traumatic brain injury.
Penumbra's history can be traced back to 2004 when it was founded by Dr. Adam Elsesser, an entrepreneur with a background in neuroscience and neurointervention. The company's name derives from the Latin word "penumbra," which refers to the partial shadow surrounding an area of complete darkness, symbolizing Penumbra's mission to bring light to dark and complex medical issues.
The company's flagship product, the Penumbra System, is a mechanical thrombectomy device that's used to remove blood clots from the brain during an ischemic stroke. This device has been a game-changer in the treatment of stroke, providing a safe and efficient alternative to traditional clot-busting drugs. Other notable products in Penumbra's portfolio include the 3D Revascularization Device, which provides mechanical support for the stent during large-vessel or complex aneurysm treatment, and the Neuron MAX System, which is used for rapid sealing of puncture holes following diagnostic or interventional neurovascular procedures.
In addition to its portfolio of medical devices, Penumbra has also developed a line of neurointensive care products, including catheters, drainage systems, and other devices that aid in the management of critically ill patients with neurological disorders. These products are designed to optimize patient outcomes and reduce complications during the recovery process.
Penumbra is committed to innovation and invests heavily in research and development to advance the quality and efficacy of its products. The company's state-of-the-art manufacturing and research facilities are located in Alameda, California, and its products are sold in over 100 countries worldwide.
Penumbra has won numerous awards and recognitions for its contributions to the field of medical technology, including the Galien USA Award for Best Medical Technology in 2011 and 2015. The company's commitment to excellence and innovation has helped make it a leader in the medical device industry and a driving force in the fight against neurovascular disorders.
Penumbra's history can be traced back to 2004 when it was founded by Dr. Adam Elsesser, an entrepreneur with a background in neuroscience and neurointervention. The company's name derives from the Latin word "penumbra," which refers to the partial shadow surrounding an area of complete darkness, symbolizing Penumbra's mission to bring light to dark and complex medical issues.
The company's flagship product, the Penumbra System, is a mechanical thrombectomy device that's used to remove blood clots from the brain during an ischemic stroke. This device has been a game-changer in the treatment of stroke, providing a safe and efficient alternative to traditional clot-busting drugs. Other notable products in Penumbra's portfolio include the 3D Revascularization Device, which provides mechanical support for the stent during large-vessel or complex aneurysm treatment, and the Neuron MAX System, which is used for rapid sealing of puncture holes following diagnostic or interventional neurovascular procedures.
In addition to its portfolio of medical devices, Penumbra has also developed a line of neurointensive care products, including catheters, drainage systems, and other devices that aid in the management of critically ill patients with neurological disorders. These products are designed to optimize patient outcomes and reduce complications during the recovery process.
Penumbra is committed to innovation and invests heavily in research and development to advance the quality and efficacy of its products. The company's state-of-the-art manufacturing and research facilities are located in Alameda, California, and its products are sold in over 100 countries worldwide.
Penumbra has won numerous awards and recognitions for its contributions to the field of medical technology, including the Galien USA Award for Best Medical Technology in 2011 and 2015. The company's commitment to excellence and innovation has helped make it a leader in the medical device industry and a driving force in the fight against neurovascular disorders.
Penumbra Inc. is a pioneering medical technology company that specializes in innovative solutions aimed at addressing some of the most complex and challenging medical conditions. The companys diverse portfolio includes multiple segments, each targeted toward specific areas of healthcare delivery, focusing primarily on improving diagnosis, treatment, and patient outcomes across critical medical disciplines such as neurology, vascular health, and cardiology.
Segments
1. Neuron
In the Neuron segment, Penumbra develops advanced products designed specifically for the diagnosis and treatment of neurovascular diseases. These conditions often include critical issues such as cerebral aneurysms, hemorrhagic strokes, and ischemic strokes. Key products in this segment include:
- Penumbra System: This represents the flagship product line that utilizes innovative mechanical thrombectomy technology to remove blood clots from the brain, thus significantly improving patient outcomes post-stroke.
- Coil 400: An embolic coil specifically designed for intracranial aneurysms, providing enhanced performance in deploying in various anatomical scenarios.
- Broughton Embolic Coil: A new addition aimed at facilitating the safe and effective treatment of intracranial aneurysms while minimizing complications.
The innovations offered by this segment drastically enhance treatment efficacy and offer healthcare providers tools to mitigate potential damage from life-threatening neurological emergencies.
Vascular
The Vascular segment focuses on peripheral vascular diseases and includes products designed for conditions such as deep vein thrombosis (DVT) and pulmonary embolisms. Important offerings in this segment comprise:
- Penumbra System with Indigo Separator: A valuable device that employs suction and separation techniques to facilitate the removal of thrombus effectively while preserving vessel integrity.
- Ruby Coil System: This is tailored for embolization procedures, providing enhanced delivery and deployment features compared to traditional coils.
- 3D Revascularization Device: An innovative solution aimed at restoring blood flow in peripheral arteries, improving overall limb perfusion and reducing the risk of tissue loss.
These products streamline interventional procedures, offering healthcare providers efficient options for treating various acute and chronic vascular conditions.
Cardiac
The Cardiac segment incorporates technologies aimed at treating a range of heart-related conditions, including cardiac arrhythmias and heart failure. Noteworthy products include:
- TRUE Flow Infusion System: Designed for delivering fluid and medications in a precise manner during cardiovascular procedures, enhancing patient safety and treatment effectiveness.
- Cobra CTO Devices: These devices are crucial for treating chronic total occlusions, facilitating access to blocked arteries and improving perfusion.
The cardiac offerings aim to empower healthcare providers in managing complex cardiac conditions, contributing to improved patient care and recovery.
Products and Services
1. Neuro Interventional Products
Penumbras Neuro Interventional products are at the forefront of stroke treatment innovations. These products are skillfully designed to support physicians in effectively managing strokes and other neurovascular crises, leading to better patient prognoses and recovery outcomes.
Peripheral Vascular Products
The Peripheral Vascular product line provides essential tools for managing vascular diseases, facilitating minimally invasive procedures that significantly lessen patient discomfort and recovery time while maximizing clinical effectiveness.
Cardiac Intervention Products
The Cardiac Intervention products reflect Penumbras ongoing commitment to enhancing cardiovascular care, providing tools that facilitate intricate diagnostics and treatments in a range of cardiac conditions.
Clinical Training and Education
Recognizing the importance of proper application of its technologies, Penumbra offers extensive training and educational initiatives. These programs are essential for healthcare providers, ranging from basic to advanced training, ensuring optimal use of the products and enhancing patient care.
Technical Support
Penumbra provides round-the-clock technical support for its healthcare partners. This service is crucial for promptly resolving issues and enabling seamless integration of Penumbra products into clinical routines, thereby boosting the confidence of practitioners using these advanced technologies.
Conclusion
In summary, Penumbra Inc. delivers a broad spectrum of advanced products and services targeted at improving the diagnosis and treatment of critical medical conditions affecting the neuro, vascular, and cardiac systems. Through its innovative technology, comprehensive training, and unwavering support, the company is dedicated to enhancing patient outcomes and ensuring healthcare providers are equipped to deliver the highest standard of care.
Segments
1. Neuron
In the Neuron segment, Penumbra develops advanced products designed specifically for the diagnosis and treatment of neurovascular diseases. These conditions often include critical issues such as cerebral aneurysms, hemorrhagic strokes, and ischemic strokes. Key products in this segment include:
- Penumbra System: This represents the flagship product line that utilizes innovative mechanical thrombectomy technology to remove blood clots from the brain, thus significantly improving patient outcomes post-stroke.
- Coil 400: An embolic coil specifically designed for intracranial aneurysms, providing enhanced performance in deploying in various anatomical scenarios.
- Broughton Embolic Coil: A new addition aimed at facilitating the safe and effective treatment of intracranial aneurysms while minimizing complications.
The innovations offered by this segment drastically enhance treatment efficacy and offer healthcare providers tools to mitigate potential damage from life-threatening neurological emergencies.
Vascular
The Vascular segment focuses on peripheral vascular diseases and includes products designed for conditions such as deep vein thrombosis (DVT) and pulmonary embolisms. Important offerings in this segment comprise:
- Penumbra System with Indigo Separator: A valuable device that employs suction and separation techniques to facilitate the removal of thrombus effectively while preserving vessel integrity.
- Ruby Coil System: This is tailored for embolization procedures, providing enhanced delivery and deployment features compared to traditional coils.
- 3D Revascularization Device: An innovative solution aimed at restoring blood flow in peripheral arteries, improving overall limb perfusion and reducing the risk of tissue loss.
These products streamline interventional procedures, offering healthcare providers efficient options for treating various acute and chronic vascular conditions.
Cardiac
The Cardiac segment incorporates technologies aimed at treating a range of heart-related conditions, including cardiac arrhythmias and heart failure. Noteworthy products include:
- TRUE Flow Infusion System: Designed for delivering fluid and medications in a precise manner during cardiovascular procedures, enhancing patient safety and treatment effectiveness.
- Cobra CTO Devices: These devices are crucial for treating chronic total occlusions, facilitating access to blocked arteries and improving perfusion.
The cardiac offerings aim to empower healthcare providers in managing complex cardiac conditions, contributing to improved patient care and recovery.
Products and Services
1. Neuro Interventional Products
Penumbras Neuro Interventional products are at the forefront of stroke treatment innovations. These products are skillfully designed to support physicians in effectively managing strokes and other neurovascular crises, leading to better patient prognoses and recovery outcomes.
Peripheral Vascular Products
The Peripheral Vascular product line provides essential tools for managing vascular diseases, facilitating minimally invasive procedures that significantly lessen patient discomfort and recovery time while maximizing clinical effectiveness.
Cardiac Intervention Products
The Cardiac Intervention products reflect Penumbras ongoing commitment to enhancing cardiovascular care, providing tools that facilitate intricate diagnostics and treatments in a range of cardiac conditions.
Clinical Training and Education
Recognizing the importance of proper application of its technologies, Penumbra offers extensive training and educational initiatives. These programs are essential for healthcare providers, ranging from basic to advanced training, ensuring optimal use of the products and enhancing patient care.
Technical Support
Penumbra provides round-the-clock technical support for its healthcare partners. This service is crucial for promptly resolving issues and enabling seamless integration of Penumbra products into clinical routines, thereby boosting the confidence of practitioners using these advanced technologies.
Conclusion
In summary, Penumbra Inc. delivers a broad spectrum of advanced products and services targeted at improving the diagnosis and treatment of critical medical conditions affecting the neuro, vascular, and cardiac systems. Through its innovative technology, comprehensive training, and unwavering support, the company is dedicated to enhancing patient outcomes and ensuring healthcare providers are equipped to deliver the highest standard of care.